Zobrazeno 1 - 10 of 400 pro vyhledávání: '"Gebreselassie, N"'
1
Akademický článek
WHO global research priorities for antimicrobial resistance in human health.
Autor: Bertagnolio S; Antimicrobial Resistance Division, WHO, Geneva, Switzerland. Electronic address: bertagnolios@who.int., Dobreva Z; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Centner CM; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Olaru ID; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Institute of Medical Microbiology, University of Münster, Münster, Germany., Donà D; Division of Paediatric Infectious Diseases, Department for Women's and Children's Health, University of Padua, Padua, Italy., Burzo S; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Huttner BD; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Chaillon A; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Gebreselassie N; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Wi T; Global HIV, Hepatitis and STI Programme, WHO, Geneva, Switzerland., Hasso-Agopsowicz M; Department of Immunization, Vaccines & Biologicals, WHO, Geneva, Switzerland., Allegranzi B; Department of Integrated Health Services, WHO, Geneva, Switzerland., Sati H; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Ivanovska V; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Kothari KU; Library and Digital Information Networks, WHO, Kobe, Japan., Balkhy HH; Antimicrobial Resistance Division, WHO, Geneva, Switzerland., Cassini A; Public Health Department, Canton of Vaud, Lausanne, Switzerland; Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland., Hamers RL; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Weezenbeek KV; Antimicrobial Resistance Division, WHO, Geneva, Switzerland.
Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Nov; Vol. 5 (11), pp. 100902. Date of Electronic Publication: 2024 Aug 13.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
Autor: Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Arcand JL; Department of International Economics, The Graduate Institute of International and Development Studies, Geneva, Switzerland.; Fondation pour les études et recherches sur le développement international (FERDI), Clermont-Ferrand, France.; Global Development Network, New Delhi, India.; Université Mohammed VI Polytechnique, Rabat, Morocco., Clark RA; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Weerasuriya CK; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Mukandavire C; Coalition for Epidemic Preparedness Innovations, London, United Kingdom., Bakker R; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; KNCV Tuberculosis Foundation, The Hague, the Netherlands., Patouillard E; Department of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland., Gebreselassie N; Global TB Programme, World Health Organization, Geneva, Switzerland., Zignol M; Global TB Programme, World Health Organization, Geneva, Switzerland., Jit M; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; School of Public Health, University of Hong Kong, Hong Kong SAR, China., White RG; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Menzies NA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Publikováno v: PLoS medicine [PLoS Med] 2023 Jul 11; Vol. 20 (7), pp. e1004252. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries.
Autor: Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, MA, USA aportnoy@bu.edu.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Clark RA; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; TB Modelling Group, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK., Weerasuriya CK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; TB Modelling Group, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK., Mukandavire C; Coalition for Epidemic Preparedness Innovations, London, UK., Quaife M; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; TB Modelling Group, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK., Bakker R; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; TB Modelling Group, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK.; KNCV Tuberculosis Foundation, Den Haag, The Netherlands., Garcia Baena I; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Gebreselassie N; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Zignol M; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Jit M; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK.; School of Public Health, The University of Hong Kong, Hong Kong SAR, People's Republic of China., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; TB Modelling Group, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK., Menzies NA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Publikováno v: BMJ global health [BMJ Glob Health] 2023 Jul; Vol. 8 (7).
Zobrazit plný text záznamu
6
Akademický článek
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
Autor: Clark RA; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: rebecca.clark@lshtm.ac.uk., Mukandavire C; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Portnoy A; Center for Health Decision Science, Harvard TH Chan School of Public Health, Boston, MA, USA., Weerasuriya CK; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Deol A; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Scarponi D; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Iskauskas A; Department of Mathematical Sciences, Durham University, Durham, UK., Bakker R; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; KNCV Tuberculosis Foundation, The Hague, Netherlands., Quaife M; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Malhotra S; Global Access, IAVI, New York, NY, USA., Gebreselassie N; Global TB Programme, World Health Organization, Geneva, Switzerland., Zignol M; Global TB Programme, World Health Organization, Geneva, Switzerland., Hutubessy RCW; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland., Giersing B; The Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland., Jit M; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Harris RC; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Global Medical Evidence Generation for Influenza Vaccines, Sanofi Pasteur, Singapore., Menzies NA; Center for Health Decision Science, Harvard TH Chan School of Public Health, Boston, MA, USA; Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA., White RG; TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v: The Lancet. Global health [Lancet Glob Health] 2023 Apr; Vol. 11 (4), pp. e546-e555.
Zobrazit plný text záznamu
7
Akademický článek
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Autor: Portnoy A; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Clark RA; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Quaife M; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Weerasuriya CK; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Mukandavire C; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Bakker R; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; KNCV Tuberculosis Foundation, The Hague, the Netherlands., Deol AK; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Coalition for Epidemic Preparedness Innovations, London, United Kingdom., Malhotra S; Market Access, Global Alliance for TB Drug Development, New York, New York, United States of America.; Global Access, International AIDS Vaccine Initiative, New York, New York, United States of America., Gebreselassie N; Global TB Programme, World Health Organization, Geneva, Switzerland., Zignol M; Global TB Programme, World Health Organization, Geneva, Switzerland., Sim SY; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Hutubessy RCW; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Baena IG; Global TB Programme, World Health Organization, Geneva, Switzerland., Nishikiori N; Global TB Programme, World Health Organization, Geneva, Switzerland., Jit M; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; School of Public Health, University of Hong Kong, Hong Kong SAR, China., White RG; TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Menzies NA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Publikováno v: PLoS medicine [PLoS Med] 2023 Jan 24; Vol. 20 (1), pp. e1004155. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023).
Zobrazit plný text záznamu
8
Defining a migrant-inclusive tuberculosis research agenda to end TB (vol 22, pg 835, 2018)
Autor: Shete, PB, Boccia, D, Dhavan, P, Gebreselassie, N, Lonnroth, K, Marks, S, Matteelli, A, Posey, DL, van der Werf, MJ, Winston, CA, Lienhardt, C
IN THE ARTICLE entitled 'Defining a migrant-inclusive tuberculosis research agenda to end TB)' (Int J Tuberc Lung Dis 2018; 22(8): 835-843, http://dx.doi.org/10.5588/ijtld.17.0503), the author names and affiliations should have read as follows.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f83100ed76767b5519781f72726b83b3
https://researchonline.lshtm.ac.uk/id/eprint/4650260/1/errata.pdf
Zobrazit plný text záznamu
9
Defining a migrant-inclusive tuberculosis research agenda to end TB [+ Erratum IJTLD.2018, vol. 22, no 10, p. 1244]
Autor: Shete, P.B., Boccia, D., Dhavan, P., Gebreselassie, N., Lönnroth, K., Marks, S., Matteelli, A., Posey, D.L., Van der Werf, M.J., Winston, C.A., Lienhardt, Christian
BACKGROUND: Pillar 3 of the End TB Strategy calls for the promotion of research and innovation at the country level to facilitate improved implementation of existing and novel interventions to end tuberculosis (TB). In an era of increasing cross-bord
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______932::42b35eb156855be1f5318253dbf904a9
http://www.documentation.ird.fr/hor/fdi:010073876
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje